symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistiskā fibroze - other respiratory system products - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
voriconazole sciecure 200 mg pulveris infūziju šķīduma pagatavošanai
sciecure pharma ltd, united kingdom - vorikonazols - pulveris infūziju šķīduma pagatavošanai - 200 mg
kaftrio
vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cistiskā fibroze - other respiratory system products - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
jimandin 100 mg apvalkotās tabletes
medochemie ltd., cyprus - sitagliptīns - apvalkotā tablete - 100 mg
adimuplan 25 mg apvalkotās tabletes
sandoz d.d., slovenia - sitagliptīns - apvalkotā tablete - 25 mg
adimuplan 100 mg apvalkotās tabletes
sandoz d.d., slovenia - sitagliptīns - apvalkotā tablete - 100 mg
adimuplan 50 mg apvalkotās tabletes
sandoz d.d., slovenia - sitagliptīns - apvalkotā tablete - 50 mg
sitagliptin grindeks 25 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 25 mg
sitagliptin grindeks 50 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 50 mg
sitagliptin grindeks 100 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 100 mg